89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
9.16
-0.34 (-3.58%)
Aug 1, 2025, 4:00 PM - Market closed
89bio Market Cap
89bio has a market cap or net worth of $1.34 billion as of August 1, 2025. Its market cap has increased by 56.59% in one year.
Market Cap
1.34B
Enterprise Value
736.01M
1-Year Change
56.59%
Ranking
Category
Stock Price
$9.16
Market Cap Chart
Since November 12, 2019, 89bio's market cap has increased from $256.62M to $1.34B, an increase of 421.09%. That is a compound annual growth rate of 33.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.34B | 45.43% |
| Dec 31, 2024 | 919.49M | -11.68% |
| Dec 29, 2023 | 1.04B | 75.74% |
| Dec 30, 2022 | 592.42M | 123.48% |
| Dec 31, 2021 | 265.09M | -45.28% |
| Dec 31, 2020 | 484.45M | 33.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.49B |
| Johnson & Johnson | 402.75B |
| AbbVie | 346.69B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.49B |
| UnitedHealth Group | 214.92B |
| Novo Nordisk | 211.90B |